Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT)

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) (USD $)
Common Stock
Additional Paid-In Capital
Retained Earnings / Accumulated Deficit
Total
Beginning balance, value at Dec. 31, 2012 $ 700 $ 143,447 $ (144,216) $ (69)
Beginning balance, shares at Dec. 31, 2012 7,000,000      
Shares issued for payment under PhytoSphere Agreement, shares 1,900,000      
Shares issued for payment under PhytoSphere Agreement, value 190 2,305,904   2,306,094
Net Income/Loss     334,399 334,399
Ending balance, value at Jun. 30, 2013 $ 890 $ 2,449,351 $ 190,183 $ 2,640,424
Ending balance, shares at Jun. 30, 2013 8,900,000